Skip to content

A randomized single blind controlled study on the prevention and treatment of allergic rhinitis with sensitive acupoint sticking therapy and its response to Th cells

A randomized single blind controlled study on the prevention and treatment of allergic rhinitis with sensitive acupoint sticking therapy and its response to Th cells

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011023
Enrollment
Unknown
Registered
2017-03-31
Start date
2016-08-23
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Treatment group:Sensitive acupoint drug application
Control group 2:Non sensitive acupoint drug application

Sponsors

Traditional Chinese Medicine Hospital of Guangdong Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) in line with AR Chinese and Western diagnostic criteria, TCM Syndrome Differentiation for deficiency syndrome (lung, spleen, kidney three dirty any dirty deficiency or more dirty deficiency), and in line with persistent allergic rhinitis standards; (2) the age between 18-65 years old, the gender is not limited; (3) subjects were informed consent, volunteer to participate in the study; (4) according to the requirements of the completion of the case observation table and other related records.

Exclusion criteria

Exclusion criteria: (1) acute rhinitis (cold), vasomotor rhinitis, autonomic nervous rhinitis, be addicted to eosinophil number of non allergic rhinitis and allergic sinusitis; (2) tape allergies; (3)local skin lesions such as burns, eczema, ulcer, chilblain burst; (4)pregnant women, women's menstrual period is suspended (after the subsidy, but should indicate the date of application); (5) due to mental or behavioral disorders can not fully cooperate with the investigation and test; (6) patients who have lost follow-up due to frequent changes in the working environment.

Design outcomes

Primary

MeasureTime frame
Total nasal symptom score;

Secondary

MeasureTime frame
The standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire;T cell subsets, cell factor, transcription factor;

Countries

China

Contacts

Public ContactJiyan Xia

Traditional Chinese Medicine Hospital of Guangdong Province

13725229838@163.com+86 13725229838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026